Clinical Trial Update: The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment [Phase 2]

View source ↗

Summary

The BARCODE 2 trial is a Phase 2 study using genetic profiling to guide treatment for hormone-refractory prostate cancer; the trial is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Hormone Refractory Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING